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Although macropinocytosis is widely recognized as a distinct form of fluid-phase
endocytosis in antigen-presenting dendritic cells, it also occurs constitutively in many
other normal and transformed cell types. Recent studies have established that various
genetic or pharmacological manipulations can hyperstimulate macropinocytosis or disrupt
normal macropinosome trafficking pathways, leading to accumulation of greatly enlarged
cytoplasmic vacuoles. In some cases, this extreme vacuolization is associated with a
unique form of non-apoptotic cell death termed “methuosis,” from the Greek methuo
(to drink to intoxication). It remains unclear whether cell death related to dysfunctional
macropinocytosis occurs in normal physiological contexts. However, the finding that some
types of cancer cells are particularly vulnerable to this unusual form of cell death has
raised the possibility that small molecules capable of altering macropinosome trafficking or
function might be useful as therapeutic agents against cancers that are resistant to drugs
that work by inducing apoptosis. Herein we review examples of cell death associated
with dysfunctional macropinocytosis and summarize what is known about the underlying
mechanisms.
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INTRODUCTION
Macropinocytosis is a clathrin-independent endocytic process
whereby mammalian cells internalize extracellular fluid inside
vesicles formed by closure of actin-rich plasma membrane pro-
trusions termed ruffles (Swanson and Watts, 1995; Kerr and
Teasdale, 2009). This process is best characterized in dendritic
cells andmacrophages, where it plays an important role in antigen
uptake and processing. However, macropinocytosis also occurs
in a broad spectrum of normal and transformed cell types. In
cancer cells it appears to contribute to cell growth by help-
ing to maintain nutrient supplies (Commisso et al., 2013; Qian
et al., 2014). Historically, insights into the molecular mechanisms
that regulate macropinocytosis lagged behind knowledge about
receptor-mediated endocytosis. Nevertheless, progress over the
past decade has revealed that macropinocytosis can occur either
constitutively or in response to external stimuli, such as EGF
(Bryant et al., 2007; Swanson, 2008). Initial steps in formation and
internalization of macropinosomes depend on cortical actin rear-
rangements, orchestrated by Rho-family GTPases, and localized
changes in membrane phosphoinositide composition (Swanson,
2008; Egami et al., 2014). Once inside the cell, macropinosomes
can recycle (Falcone et al., 2006; Bryant et al., 2007; Donaldson
et al., 2009) ormature through endosomal intermediates tomerge
with the lysosomal compartment (Racoosin and Swanson, 1993).
GTPases of the Arf and Rab families play key roles in these pro-
cesses (Sun et al., 2003; Donaldson et al., 2009; Feliciano et al.,
2011). Recent studies by our group and others have demonstrated
that dysregulation of macropinocytosis, triggered by molecular or
pharmacological manipulation of cultured cells, can have striking
consequences for cell viability, especially in some types of cancer
cells (Overmeyer et al., 2008, 2011; Kitambi et al., 2014). In these
instances, hyperstimulation of macropinosome biogenesis, cou-
pled with defects in the pathways for macropinosome recycling
and/or maturation, results in extreme cytoplasmic vacuolization.
This is followed by a unique form of cytolytic death that is some-
what selective for tumor cells and is distinct from apoptosis or
other non-apoptotic cell death pathways (e.g., autosis, paraptosis,
necroptosis). The concept that pharmacological induction of this
type of cytopathology could be useful in devising new approaches
to cancer therapy in tumor cells that are refractory to apopto-
sis has generated considerable interest (Gilbertson, 2014). In this
review we summarize the salient features of several reported cases
where perturbations of macropinocytosis have been linked to cell
death, and we conclude with a discussion of some of the out-
standing questions that need to be resolved as this field of inquiry
matures.
CELL DEATH INDUCED BY ACTIVATION OF RAS AND RAC
PATHWAYS
The initial description of cell death triggered by hyperstimula-
tion of macropinocytosis emerged from attempts to characterize
an unusual phenotype observed in human glioblastoma cells fol-
lowing ectopic expression of the constitutively active oncoprotein,
H-Ras(G12V). Instead of a growth stimulatory effect, Chi et al.
(1999) found that Ras expression induced the accumulation of
multiple large phase-lucent cytoplasmic vacuoles, followed by
caspase-independent cell death. Although this was inferred to be
a form of autophagic cell death, the vacuoles did not exhibit the
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expected double-membrane morphology with degradative con-
tents expected for autophagosomes. In a subsequent study, we
established that the Ras-induced vacuoles were in fact derived
from macropinosomes, based on electron microscopy demon-
strating their origination from plasma membrane projections
(Overmeyer et al., 2008). Consistent with the known role of Ras
in macropinosome biogenesis (Bar-Sagi and Feramisco, 1986; Li
et al., 1997; Porat-Shliom et al., 2008), immuofluorescence stud-
ies revealed that epitope-tagged H-Ras(G12V) was localized to
the membranes of the vacuoles (Overmeyer et al., 2008). Studies
with fluorescent fluid-phase tracers suggested that, unlike normal
macropinosomes, the Ras-induced vacuoles did not regurgitate
their contents by recycling back to the cell surface. Although
the vacuoles acquired some characteristics of late endosomes
(LAMP1, Rab7), they did not appear to merge with vesicular
compartments labeled with acidotrophic dyes (LysoTracker®) or
a cathepsin B substrate (Magic Red RR™) (Overmeyer et al.,
2008). These findings supported a model wherein constitutive
Ras activation caused extreme endosomal vacuolization not just
because of an increase in macropinocytotic activity, but because
normal pathways for recycling and eventual lysosomal fusion of
macropinosome-derived endosomal vesicles were impaired.
Glioblastoma cells expressing Ras(G12V) lost viability over
a period of 4–6 days (Overmeyer et al., 2008). The mor-
phological features of the dying cells were distinct from cells
undergoing apoptosis. In particular, the cytoplasmic space was
almost entirely occupied by massive clear vacuoles, but the
nuclei did not undergo chromatin condensation or fragmen-
tation typically associated with apoptosis (Figure 1). As vac-
uolization became more extreme, the vacuolated cells exhibited
signs of membrane disruption reminiscent of necrosis. Although
autophagosomes accumulated in cells expressing activated Ras,
these structures were distinct from the macropinosome-derived
vacuoles (Overmeyer et al., 2008). Others have shown that Ras-
induced autophagy can contribute to non-apoptotic death in
some cell types (Elgendy et al., 2011; Wang et al., 2014), but
we found that suppressing the expression of autophagy pro-
teins (e.g., Beclin-1) did not prevent Ras-induced vacuolization
or cell death in glioblastoma cells (Overmeyer et al., 2008).
The foregoing observations, combined with the inability of a
broad-spectrum caspase inhibitor (zVAD-fmk) and the necrop-
tosis inhibitor (necrostatin) to protect glioblastoma cells from
Ras-induced cell death, prompted us to propose that the degener-
ative changes associated with dysregulation of macropinocytosis
could represent a novel type of necrotic cell death (Overmeyer
et al., 2008). Because of the connection to macropinocytosis
(often referred to as cell drinking), we coined the term “methu-
osis” (from the Greek word methuo, which means to drink to
intoxication) to describe this form of cell death.
Our follow-up studies (Bhanot et al., 2010) provided insights
into the mechanisms responsible for Ras-induced methuosis by
demonstrating that the Rac1 GTPase is a key downstream media-
tor. Extreme vacuolization of endosomal compartments induced
by H-Ras(G12V) was observed only when Ras expression reached
a level sufficient to promote an increase in the activation of
endogenous Rac1. Moreover, a specific inhibitor of Rac1 acti-
vation (EHT1864) impeded the accumulation of Ras-induced
vacuoles. Finally, ectopic expression of activated Rac1, but not
other Rho GTPases, was able to mimic the morphological effects
of activated H-Ras. The importance of Rac1 as a mediator of
FIGURE 1 | Examples of extreme vacuolization of macropinosomes
associated with non-apoptotic cell death (methuosis) in U251
glioblastoma cells. (A,B) Show phase contrast and electron microscopy
images of a stable U251 cell line in which overexpression of H-Ras(G12V)
was induced for a period of 4 days (reprinted with permission from
Overmeyer et al., 2008). Similar images of U251 cells treated with the indolyl
chalcone, MIPP, were obtained after 3 days (C) or 2 days (D) of drug
treatment (reprinted with permission from Overmeyer et al., 2011).
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Ras-stimulated macropinocytosis was not surprising, in light of
previous reports by others establishing the role of Rac1 in the ini-
tial steps of macropinosome formation and trafficking (Ridley,
2001; Fujii et al., 2013). However, the difficulty of envisioning
a scenario where stimulation of macropinocytosis alone could
account for the development of extreme vacuolar cytopathol-
ogy prompted us to postulate that Arf6, a GTPase known to
function in macropinosome recycling (Radhakrishna et al., 1999;
Grant and Donaldson, 2009), might be affected by constitu-
tive activation of Ras (Bhanot et al., 2010). We found that in
glioma cells expressing H-Ras(G12V), there was an inverse rela-
tionship between the activation states of endogenous Rac1 and
Arf6. That is, as the relative amount Rac1-GTP increased, the
amount of Arf6-GTP decreased. The decline in the pool of active
Arf6 was linked to Rac1-mediated activation of an Arf6 GAP,
GIT-1, since the decline in active Arf6 was abrogated in cells
where GIT-1 expression was suppressed by shRNA. These find-
ings suggested that Ras-induced methuosis might be due to the
combined effects of an increase in macropinosome formation
and a decrease in macropinosome recycling (Bhanot et al., 2010).
However, the apparent inability of the enlarged LAMP1-positive
vacuoles to be eliminated by eventual fusion with lysosomes sug-
gests that additional defects at the late endosome-lysosome inter-
face also may contribute to the methuosis phenotype triggered
by Ras.
Although Ras-induced vacuolization of macropinosome com-
partments has been studied mainly in human glioma cells
(Overmeyer et al., 2008; Bhanot et al., 2010), similar observations
in gastric carcinoma cells (Chi et al., 1999) and osteosarcoma cells
(Bhanot et al., 2010), suggest that this novel effect of Ras overex-
peression is not restricted to brain cancers. In fact, a report show-
ing that expression of activated Ras inAspergillus fumigatus causes
excessive vacuolar expansion and lysis of hyphal compartments
(Fortwendel et al., 2011) has raised the possibility that a similar
Ras-mediated methuosis pathway might be conserved in lower
eukaryotes. These surprising findings are at odds with the large
body of work showing that endogenous Ras proteins with acti-
vating mutations typically promote cell proliferation and tumor
progression, rather than cell death (Downward, 2003; Shaw and
Cantley, 2006). Indeed, our work with a “tunable” expression
system suggests that the hyperstimulation of macropinocytosis
and attendant vacuole formation require artificially high levels of
ectopic Ras(G12V) expression (Bhanot et al., 2010). Nevertheless,
by gaining a better understanding of the mechanisms that trigger
this unusual form of cytopathology, it may be possible to develop
pharmacological strategies to induce methuosis in a therapeutic
context to kill cancer cells that are resistant to apoptosis because
of tumor suppressor mutations or heightened DNA repair
capacity.
METHAMPHETAMINE-INDUCED PERTURBATIONS OF
MACROPINOCYTOSIS
In the course of studies aimed at identifying potential mech-
anisms whereby methamphetamine (METH) can cause death
of neurons in the central nervous system, Nara et al. (2010)
observed a unique cell death phenotype reminiscent of methu-
osis in differentiated cultures of SH-SY5Y neuroblastoma cells. In
particular, they noted that when cells were treated with METH,
they became filled with phase-lucent vacuoles and began to die
by a caspase-independent process within 24 h. They concluded
that the vacuoles were derived from macropinosomes, based on
their incorporation of high-molecular-weight fluid-phase dex-
tran tracers and prevention of the phenotype by inhibitors of
macropinocytosis like cytochalasin D and amiloride. METH-
induced perturbation of macropinocytosis was accompanied by
accumulation of autophagosomes. However, as in the case of Ras-
induced methuosis, the autophagosomes were distinct from the
macropinosome-derived vacuoles and autophagy was dispensable
for cell death, as evidenced by studies with autophagy inhibitors
(Nara et al., 2010).
In a follow-up study, the same investigators provided evi-
dence that hyperstimulation of macropinocytosis in neuroblas-
toma cells exposed to METH involves activation of Ras and
Rac1, based on immunofluorescence localization of activated
forms of these GTPases on the METH-induced vacuoles (Nara
et al., 2012). Moreover, they showed that both the Rac inhibitor,
EHT1864, and the Ras farnesylation inhibitor, farnesyl thiosal-
icylic acid, could inhibit the formation of vacuoles. In seeking
to explain the possible mechanism for the cytotoxic effects of
METH, it was noted that proteolytic activation of the lysoso-
mal enzyme, cathepsin L, was impaired in cells treated with
METH. Thus, the authors proposed that cell death might be
precipitated by defects in lysosomal function. The precise rela-
tionship between increased incoming macropinosome traffic and
lysosomal dysfunction remains unclear. The model suggested
by Nara et al. (2012) postulates that lysosomal defects arise
from alkalization due to an abnormally high level of fusion
with incoming macropinosomes. The evidence for normal fusion
of macropinosomes with lysosomes was the co-localization of
some FITC-dextran-labeled vacuoles with LAMP1. However,
it is well established that LAMP1 can be detected on non-
lysosomal compartments, such as late endosomes and late-stage
macropinosomes (Humphries et al., 2011; Egami and Araki,
2012; Pols et al., 2013). Thus, it remains possible that, just as
in Ras-induced methuosis, there could be a block in trafficking
between macropinosome-derived endosomal vacuoles and lyso-
somal compartments in cells treated with METH. Such a block
in endolysosomal trafficking could account for the impaired pro-
teolytic maturation of cathepsin L, which depends on delivery
of procathepsin L to lysosomes from late endosomal vesicles
(Ishidoh et al., 1999).
Another explanation for the apparent endolysosomal defects
and neuronal toxicity of METH has been suggested by the work
of Cubells et al. (1994). In their model, METH can act directly
as an acidotrophic weak base to disrupt endosomal and lyso-
somal pH gradients, promoting both osmotic swelling of these
compartments and redistribution of dopamine to generate toxic
metabolites. As studies move forward to address the potential
involvement of dysfunctional macropinocytosis in the neuro-
toxicity of METH, it will be important to consider the critical
question of whether studies done with cultured cells exposed to
millimolar concentrations of METH truly reflect the mechanisms
of cytotoxicity that operate in the brains of METH abusers, where
physiological levels of METH may be much lower.
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DEATH BY MACROPINOCYTOSIS INDUCED VIA ACTIVATION
OF A RECEPTOR TYROSINE KINASE
Ligand-mediated activation of the EGF receptor and other recep-
tor tyrosine kinases typically results in their incorporation into
clathrin-coated endosomes, where signaling can persist until the
receptors are internalized into multivesicular bodies and directed
to lysosomes for degradation (Katzmann et al., 2002). However,
some neurotrophin receptors (e.g., TrkA) appear to be capable
of generating prolonged signals because they reside in a distinct
population of comparatively stable endosomal vesicles gener-
ated through a Rac-dependent macropinocytotic process (Valdez
et al., 2007). In contrast to its role in promoting survival and
differentiation of normal neuronal cells, activation of TrkA in
neuroblastoma or medulloblastoma cells can trigger cell death
(Chou et al., 2000; Lavoie et al., 2005; Li et al., 2010). Most inter-
esting in relation to this review, Li et al. (2010) reported that
NGF stimulation of Daoy medulloblastoma cells stably express-
ing TrkA causes hyperstimulation of macropinocytosis, extreme
cellular vacuolization and caspase-independent cell death.
As in the preceding examples of cell death associated with
abnormal macropinocytosis, siRNA-mediated knockdown of
autophagy proteins (e.g., Beclin-1, Atg5, LC3) did not prevent
the accumulation of vacuoles or cell death in NGF-stimulated
medulloblastoma cells (Li et al., 2010). However, some of the
macropinosome-derived vacuoles were capable of incorporating
the autophagosome marker, EGFP-LC3, and merging with lyso-
somes. A possible explanation for these paradoxical observations
is suggested by the work of Florey et al. (2011), demonstrating
that ectopically expressed GFP-LC3 can be recruited directly to
macropinosomes, where it may play a role in downstream fusion
with endosomal and lysosomal compartments. In attempting to
examine the possible mechanisms underlying the TrkA-mediated
induction of cell death, Li et al. (2010) made the intriguing obser-
vation that a specific inhibitor of casein kinase 1 (CK1) was able
to block both the induction of macropinocytosis and the asso-
ciated death of the medulloblastoma cells caused by activation
of TrkA. At present it remains unclear which targets of CK1
might be involved in regulating macropinocytosis. Nevertheless,
this finding is important because it supports the concept that
macropinocytosis is mechanistically linked to cell death in this
system.
MACROPINOSOME VACUOLIZATION AND CELL DEATH
INDUCED BY SMALL MOLECULES
Following our initial description of Ras-induced cell death
associated with vacuolization of macropinosome-derived endo-
somal compartments (methuosis), we identified a series of
small molecules that induced a very similar form of cell
death in a Ras-independent manner (Overmeyer et al., 2011;
Robinson et al., 2012). The prototype was a synthetic indole-
based chalcone termed MIPP; an acronym for 3-(2-methyl-1H
indol-3-yl)-1-(4-pyridinyl)-2-propen-1-one. At low micromolar
concentrations MIPP triggered rapid accumulation of numer-
ous phase-lucent cytoplasmic vacuoles when applied to human
glioblastoma cells (Figure 1). Time-lapse microscopy revealed
waves of macropinosomes entering the cells between 13 and
80min after addition of the compound (Overmeyer et al.,
2011). Nascent vesicles rapidly coalesced to form large vac-
uoles, and eventually the influx of macropinosomes slowed
down. Treatment of cells with filipin (a cholesterol binding
agent) blocked vacuole formation, consistent with the known
dependence of macropinocytosis on cholesterol-rich membrane
domains (Castro-Obregon et al., 2004). The MIPP-induced vac-
uoles acquired Rab7 and LAMP1, indicative of a transition
from macropinosomes to enlarged late endosomal structures.
However, there was little or no overlap between the phase-
lucent vacuoles and compartments labeled with markers for lyso-
somes (LysoTracker, Magic Red RR) or autophagosomes (LC3II),
suggesting a defect at the late endosome-lysosome boundary.
Within 2 days after addition of MIPP there was a decline in
cellular ATP levels and cell viability (Overmeyer et al., 2011).
A non-apoptotic mode of death was supported by the fact that
while the plasma membrane was disrupted, the nuclear mem-
brane stayed intact and chromatin remained diffuse (Figure 1).
Although there was some caspase activation (PARP cleavage), the
caspase inhibitor, zVAD-fmk, did not prevent loss of viability.
Overall, except for an accelerated evolution of macropinocytotic
vacuoles and amore rapid pattern of cell death, the cytopathology
of cells exposed to MIPP was very similar to the methuosis phe-
notype we described in cells expressing H-Ras(G12V) (Figure 1).
It is worth noting that the activation states of Rac1 and Arf6 were
not altered by MIPP. However, there was marked decline in active
Rab5 (Overmeyer et al., 2011), a GTPase that plays a key role in
early endosomal trafficking, including macropinosome matura-
tion (Feliciano et al., 2011). These observations suggest thatMIPP
operates at stages of macropinosome biogenesis and endolysoso-
mal trafficking downstream from the early steps regulated by Ras,
Rac1, and Arf6.
Our continuing studies with synthetic libraries of MIPP-
related compounds have identifiedmore potent derivatives (e.g., a
5-methoxy derivative, MOMIPP) (Robinson et al., 2012; Trabbic
et al., 2014). The abrogation of methuosis by very minor changes
in the structures of these compounds (e.g., changing the con-
figuration of the pyridinyl nitrogen from para to meta) suggests
that the effects of these compounds are due to interactions with
specific intracellular protein targets, rather than general covalent
protein modification byMichael addition. However, the identities
of the targets have not yet been established.
Kitambi et al. (2014) recently reported the results of a phe-
notypic screen in which they identified an entirely different class
of small molecules termed Vacquinols, which have the ability
to kill glioblastoma cells through a process involving massive
membrane ruffling, accumulation of macropinosome-derived
vacuoles, decreased ATP, and rupture of the cell membrane. This
process, which they termed catastrophic vacuolization, is insen-
sitive to inhibitors of caspase activation, autophagy and necrop-
tosis, and exhibits most of the hallmarks of methuosis. The lead
compound, Vacquinol-1, had excellent pharmacokinetic proper-
ties and showed good anti-tumor efficacy against glioblastoma in
zebrafish and mouse models. Unlike the indolyl chalcones, the
cytotoxic activity of the Vacquinols so far appears to be rela-
tively selective for glioblastoma. Although the protein targets of
the Vacquinols remain to be defined, an unbiased shRNA screen
revealed that the activity of a MAP kinase kinase, MKK4, was
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required for induction of macropinocytosis and cell death by
Vacquinol-1 (Kitambi et al., 2014). There is some evidence that
MKK4 functions downstream of Rac1 in the JNK pathway (Wang
et al., 2014), but it remains to be determined how MKK4 might
function in macropinosome biogenesis and trafficking.
OTHER STIMULI CAUSING ABNORMALITIES IN
MACROPINOCYTOSIS
With increasing awareness that hyperstimulation of
macropinocytosis or disruption of normal macropinosome
trafficking can result in loss of cell viability, it is likely that
additional triggers for such forms of cell death will be discovered.
Two recent examples illustrate this trend.
The first example comes from studies seeking to identify dys-
regulated miRNAs in papillary thyroid carcinoma, which revealed
miR-199a-3p as a potential tumor suppressor (Minna et al.,
2014). Restoration of miR-199a-3p in cells that underexpress this
molecule caused the tumor cells to die by a non-apoptotic path-
way resembling methuosis, with characteristic accumulation of
cytoplasmic vacuoles derived from macropinosomes. Although
the precise molecular mechanisms linking miR-199a-3p to this
lethal phenotype remain to be defined, the authors noted that a
number of genes involved in the regulation of macropinocytosis
are among the predicted targets of miR199a-3p.
A second example comes from studies of AS1411, a 26-base
G-rich oligonucleotide that binds to nucleolin as an aptamer and
selectively induces cell death in a broad spectrum of cancer cells,
but not normal cells (Bates et al., 2009; Choi et al., 2010). Reyes-
Reyes et al. (2010) reported that after its initial uptake via basal
macropinocytosis, AS1411 acts in a nucleolin-dependent manner
to further stimulate macropinocytosis in cancer cells. Nucleolin
exhibits oncogenic synergism with active Ras and ErbB and co-
localizes with these proteins at the plasma membrane (Schokoroy
et al., 2013). However, it remains unclear whether the effects of
AS1411 on macropinocytosis may be mediated through nucle-
olin interaction with Ras or its downstream effectors. In addition,
it will be important to ascertain if stimulation of macropinocy-
tosis by AS1411 is directly responsible for the selective cytotoxic
activity of this aptamer in cancer cells.
FUTURE DIRECTIONS
Although it is well established that macropinocytosis plays a vital
role in many different types of cells under normal physiologi-
cal circumstances, the recognition that artificial perturbation of
macropinocytosis can lead to a novel form of non-apoptotic death
in cancer cells is a relatively recent development. Figure 2 sum-
marizes the various molecular or pharmacological stimuli that
have been reported to cause vacuolization of macropinosome-
derived compartments. Common features in all of these scenarios
include transient or sustained stimulation of macropinocytosis,
dysfunctional recycling and/or lysosomal-directed trafficking of
the resulting macropinosomes, and swelling/coalescence of inter-
mediate vesicular compartments. Typically these effects have been
documented in cancer cells, where constitutive macropinocy-
tosis can be more active than is commonly appreciated. This
has raised the possibility that manipulation of macropinocytosis
pathways could represent a novel strategy for killing malignant
cells that are inherently resistant to apoptosis, due to mutations
in tumor suppressor genes that control responses to DNA dam-
age or oxidative stress (Delbridge et al., 2012). Furthermore,
one might envision that inducing cytolysis via accumulation
of macropinosome-derived vacuoles could circumvent the well-
known ability of tumor cells to adapt to conventional chemother-
apeutic drugs by increasing their DNA repair capacity or drug
efflux pathways (Bocangel et al., 2002; Dean et al., 2005;
Abdullah and Chow, 2013). Our preliminary studies have pro-
vided some support for the latter concept by demonstrating
that methuosis-inducing compounds, MIPP and MOMIPP, can
be effective in killing temozolomide-resistant glioblastoma cells
and doxorubicin-resistant breast cancer cells in vitro (Overmeyer
et al., 2011; Robinson et al., 2012). To further explore the pos-
sibility that apoptosis-resistant cancer cells might be vulnerable
to an alternative form of cell death triggered by dysfunctional
macropinocytosis, it will be important to address several key
questions:
(1) Are tumor cells more vulnerable to disruption of
macropinocytosis than normal cells and, if so, what is the
basis for this difference? Vacquinol-1 exhibits toxic activity
against glioblastoma, but not human fibroblasts or normal
embryonic stem cells (Kitambi et al., 2014). MIPP and
MOMIPP show variable levels of cytotoxicity against tumor
cells in addition to glioblastoma. Yet, as in the case of
Vacquinol-1, normal fibroblasts or mammary epithelial
cells are less sensitive to these compounds (Overmeyer
et al., 2011; Robinson et al., 2012). Interestingly, despite
reduced effects on cell viability, treatment of normal fibrob-
lasts or epithelial cells with MOMIPP still causes striking
vacuolization of endosomal compartments in these cells
(Robinson et al., 2012). Why then does vacuolization have
a more severe impact on viability in tumor cells compared
with normal cells? One possible explanation could be that
the consequences of dysfunctional macropinocytosis and
cytoplasmic vacuolization are more immediate in rapidly
proliferating cancer cells compared with slower-growing
contact-inhibited normal cells. Alternatively, it is possible
that cancer cells may be more dependent on macropinocy-
tosis than normal cells for acquisition of nutrients, so that
disruption of macropinosome trafficking to the lysosomes
has a greater impact on cellular metabolism and ATP levels.
Finally, it is conceivable that the vacuoles generated by
methuosis-inducing compounds in tumor cells are qualita-
tively different from those induced in normal cells, either in
terms of their origin or their ability to trigger stress pathways
that can lead to cell death.
(2) What specific signaling pathways are involved in triggering
vacuolization of macropinosome compartments? The limited
information concerning signaling pathways implicated in
the hyperstimulation of macropinocytosis or vacuolization
of macropinosome-derived compartments is summarized
in Figure 3. Activation of Rac1 plays an important role in
some cases, particularly those triggered by overexpression
of Ras(G12V) or treatment with METH. In other examples,
kinases not previously linked to macropinocytosis appear to
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FIGURE 2 | Perturbations of macropinocytosis associated with cell
death. A molecular or pharmacological stimulus triggers a vigorous increase
in membrane ruffling and formation of macropinosomes. This may be
sustained (as in Ras or TrkA stimulation) or transient (MIPP treatment). Once
generated, the incoming macropinosomes give rise to a multitude of large
vacuoles that fill much of the cytoplasmic space. Studies with MIPP indicate
that vacuole enlargement occurs through fusion events, although osmotic
swelling has not been ruled out conclusively in most cases. Defective
recycling of macropinosomes contributes to vacuole formation in specific
instances (Ras or Rac overexpression, treatment with MIPP), but this has not
been examined in all examples. The vacuoles are able to mature to acquire
late endosomal characteristics, such as LAMP1 or Rab7, but they generally
remain separate from autophagosomes and are not dissipated by
suppressing the expression of autophagy proteins. Conclusions about the
ability of the vacuoles to merge with lysosomes vary. The vacuoles generated
by Ras, Rac, MIPP, and MiR-199a-3p appear to be defective in their ability to
fuse with lysosomes, whereas those generated by TrkA stimulation and
METH exhibit some overlap with lysosomal compartments. Ultimately,
metabolic failure and loss of membrane integrity occur, but the specific
mechanisms linking vacuolization to these sequelae have not been defined.
be involved (e.g., MKK4 in the case of Vacquinol-1, and
CK1 in the case of NGF-TrkA). The specific GEF (gua-
nine nucleotide exchange factor) that links Ras to Rac1 in
the context of methuosis remains a mystery. Our experi-
ments utilizing shRNAs to suppress the expression of two
likely candidates, Tiam1 and Eps8 (a component of the
Sos1/Eps8/E3b1 complex), did not reveal any inhibition of
H-Ras-induced macropinocytosis and vacuolization (Bhanot
et al., 2010).
As noted earlier, overexpression of Rac1(G12V) can induce
the methuosis phenotype directly, independent of Ras. This
requires interaction of Rac1 with specific effectors, since
neither Cdc42(G12V) nor RhoA(G14V) produced the same
phenotype (Kaul et al., 2007). Other Rho-family GTPases
have not yet been examined, but RhoG merits consideration
since it has been reported to stimulate membrane ruffling
and macropinocyctosis (Ellerbroek et al., 2004) and can acti-
vate Rac1 in response to EGF or HGF in glioblastoma cells
(Kwiatkowska et al., 2012). Identification of the Rac1 effec-
tors involved in promoting methuosis is still incomplete.
When expressed at high levels, Rac1(G12V) appears to cause
a decline in the level of active Arf6, presumably through stim-
ulation of the Arf6 GAP, GIT-1. While this may account for
the block in macropinosome recycling, the basis for hyper-
stimulation of macropinosome biogenesis remains unclear.
One Rac1 effector that could be involved is p21-activated
kinase-1 (PAK1), which is known to enhance macropinocy-
tosis by promoting actin remodeling and membrane ruf-
fling (Dharmawardhane et al., 2000). However, in unpub-
lished studies we have noted that co-expression of the PAK1
autoinhibitory domain with Rac1(G12V) does not abro-
gate macropinosome vacuolization. Other Rac1-reponsive
proteins that could play roles in formation of membrane ruf-
fles and macropinosomes include POR1 (Van Aelst et al.,
1996) and the WAVE2/Abi1 complex (Innocenti et al., 2004;
Dubielecka et al., 2010). Interestingly, Abi1 is one of the pre-
dicted targets of miR-1991-3p, which induces macropinocy-
totic vacuoles and causes non-apoptotic death in papillary
thyroid carcinoma cells (Minna et al., 2014).
With the identification of small molecules, exemplified by
MIPP, MOMIPP, and Vacqinol-1, which may have therapeu-
tic potential to induce methuosis-like cell death in cancer,
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FIGURE 3 | Overview of signaling pathways implicated in
hyperstimulation of macropinocytosis and vacuolization of
macropinosome-derived compartments. Known stimuli discussed in
this review are shown in blue. Dashed lines denote pathways where
specific mechanisms and intermediates are not yet defined. Some
pathways may be operational only in certain cell types. The effects of
constitutively active Ras and high concentrations of METH require
activation of Rac1. In addition to altering the amount of active Arf6 via
GIT-1, sustained activation of Rac1 has the potential to affect multiple
protein targets known to function in actin remodeling, membrane ruffling
and initial steps of macropinocytosis (e.g., PAK1, POR1, WAVE2). The
effects of NGF in cells overexpressing TrkA depend on casein kinase 1
(CK1), but the specific function of CK1 in macropinocytosis is obscure.
The effects of Vacquinol-1 require MKK4, a downstream component of
the Rac1-JNK stress signaling pathway. It is not yet clear how MKK4
functions in macropinosome biogenesis or trafficking. The compounds
MIPP and MOMIPP, have inverse effects on the activation states of Rab5
(macropinosomes and early endosomes) and Rab7 (late endosomes).
They probably exert their effects by altering vesicular trafficking steps
downstream from those regulated by Rac1 and Arf6.
future efforts undoubtedly will focus on identifying the tar-
gets of these compounds. Although such studies are in their
early stages, we have noted that induction of methuosis by
MIPP is distinct from Ras-induced methuosis insofar as it
does not entail alterations in the activation states of Rac1
or Arf6. On the other hand, MIPP causes a marked decline
in active Rab5 (Overmeyer et al., 2011), which is critical for
macropinosome stabilization (Feliciano et al., 2011). This
could occur through a number of possible mechanisms,
including direct interference of the compound with Rab5
activation by GEFs (e.g., Rabex-5, Rin1), accelerated Rab5
inactivation by GAPs, indirect disruption of the Rab5 cycle
due to changes in endosomal membrane structure or pH,
or premature recruitment of Rab7, which inhibits Rabex-
5 (Rink et al., 2005; Poteryaev et al., 2010; Feliciano et al.,
2011). Consistent with the latter idea, themembranes ofmost
of the vacuoles induced by MIPP contained Rab7, and the
overall amount of active Rab7 was elevated in MIPP-treated
cells (Overmeyer et al., 2011). An important question for
future consideration is why these macropinosome-derived
vacuoles fail to dissipate bymerging with lysosomal compart-
ments, despite showing some signs of late endosomal matu-
ration (i.e., acquisition of Rab7 and LAMP1). At the present
time there is no available information about the potential
interaction of methuosis-inducing compounds with proteins
that maintain endosomal proton gradients or function in late
endosome lysosome trafficking pathways.
(3) What is the relationship between vacuolization of
macropinosome-derived compartments and cell death? All of
the examples of cell death associated with perturbations
of macropinocytosis share some common features, which
are summarized in the model depicted in Figure 2. Once
vacuolization of macropinosome-derived compartments
occurs, the exact execution steps that lead to the demise of
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the cell remain poorly defined. Depending on the specific
stimulus, caspase activation may or may not occur, but it
is clear that caspase inhibitors afford little or no protection
from death. Moreover, nuclear changes typical of apoptosis
are uniformly absent. On the other hand, decreased ATP and
loss of membrane integrity, reminiscent of necrosis, appear
to be common outcomes in these forms of cell death. A
key question is whether vacuolization of endosomal com-
partments is directly responsible for triggering cell death.
Pharmacological approaches to block macropinocytosis by
interfering with the actin cytoskeleton (cytochalasin D),
Na+/H+ exchange (amiloride) or the vacuolar-type H+-
ATPase (bafilomycin-A1) have limited utility for delineating
the pathways that lead to cell death, because these agents
are themselves cytotoxic when applied to cells for prolonged
periods of time. However, studies involving inhibition of spe-
cific protein kinases support the notion that there is a causal
relationship between dysfunctional macropinocytosis and
cell death. For instance, blocking TrkA-induced formation of
macropinocytotic vacuoles by treatment of medulloblastoma
cells with the CK1 inhibitor, D4476, prevented cell death (Li
et al., 2010). Similarly, suppressing the expression of MKK4
in glioblastoma cells impeded the induction of vacuolization
by Vacquinol-1, and concomitantly reduced the cytotoxic
effect of the compound (Kitambi et al., 2014). A final line of
correlative evidence, based on structure-activity relationships
of MIPP-related indolyl chalcones, lends credence to the
idea that vacuolization of macropinosomes is an important
component of the cell death program. Specifically, we noted
that minor structural changes that eliminated the ability of
compounds to induce macropinosome vacuolization also
eliminated their ability to kill glioblastoma cells (Robinson
et al., 2012). Notwithstanding this body of evidence, our
most recent results suggest that some caution is warranted
in concluding that vacuolization of macropinosome-derived
compartments is, by itself, sufficient to trigger cell death. In
particular, we identified a sub-group of indolyl chalcones
that induced robust vacuolization in glioblastoma cells
without substantially inhibiting proliferation or viability
(Trabbic et al., 2014). This raises the possibility that, in
at least some cases, cell death associated with accumu-
lation of macropinosome-derived vacuoles may entail
unrecognized pleiotropic effects on vital cellular processes
beyond macropinocytosis. In this situation, one might
view hyperstimulation of macropinocytosis or disruption
of macropinosome trafficking as essential priming events
that combine with other cellular insults to cause eventual
metabolic collapse. In this regard it will be interesting
to study in greater detail the interrelationships between
macropinocytotic dysfunction and cellular bioenergetic
pathways, stress responses, cytoskeletal architecture and
lysosomal integrity.
Even if agents that hyperstimulate macropinocytosis or inter-
fere with macropinosome recycling pathways do not always
lead directly to cell death, one might speculate that such
agents could have benefits in other contexts. One possibility
is that stimulation of macropinocytosis might be utilized to
increase fluid-phase drug uptake in resistant cancer cells where
induction of ABC transporters promotes rapid efflux of drugs
entering via conventional transmembrane routes. Alternatively,
one might envision that stimulation of macropinocytosis
could be harnessed to facilitate uptake of drugs packaged
in nanoparticle delivery vehicles. Finally, recent studies have
established that cancer cells utilize Arf6-dependent mechanisms
to generate and release plasma-membrane derived microvesi-
cles containing proteases and other factors that can promote
invasion and tumor progression (Muralidharan-Chari et al.,
2009, 2012). It would be interesting to determine whether
molecular or pharmacological manipulations that impede
macropinosome recycling might also affect the release of such
microvesicles.
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